EMEA-002261-PIP01-17

Key facts

Active substance
Ferric pyrophosphate citrate
Therapeutic area
  • Haematology-Hemostaseology
  • Uro-nephrology
Decision number
P/0263/2018
PIP number
EMEA-002261-PIP01-17
Pharmaceutical form(s)
  • Solution for infusion
  • Solution for haemodialysis
Condition(s) / indication(s)
Treatment of anaemia of chronic kidney disease
Route(s) of administration
  • Intravenous use
  • Haemodialysis
Contact for public enquiries
Rockwell Medical, Inc.

Tel.  +1 2489609009
E-mail: rpratt@rockwellmed.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating